Pfizer 2014 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 45
ANNUAL REVIEW 2014
Our Science > Our Pipeline
As of February 27, 2015
VIEW THE LATEST PIPELINE ON PFIZER.COM
OUR PIPELINE
PROGRAMS IN CLINICAL TRIAL
OR REGISTRATION
We prioritize our R&D efforts in areas with the greatest scientific and commercial
promise: immunology and inflammation, cardiovascular and metabolic diseases,
oncology, vaccines, neuroscience and pain, rare diseases, and biosimilars. Through
major research efforts across multiple modalities — including small molecules,
biologics and vaccines — Pfizer is researching and developing unique therapies
that will matter most to the people we serve.
Q: HOW DOES PFIZER CHOOSE WHAT
MEDICINES TO FOCUS R&D EFFORTS ON?
JULIE SCHIFFMAN
PORTFOLIO & DECISION ANALYSIS